EFFICACY AND SAFETY OF ALIROCUMAB VERSUS PLACEBO ON TOP OF MAXIMALLY TOLERATED LIPID LOWERING THERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA WHO HAVE TYPE 1 OR TYPE 2 DIABETES AND ARE TREATED WITH INSULIN (ODYSSEY DM - INSULIN):